-
公开(公告)号:US20150209485A1
公开(公告)日:2015-07-30
申请号:US14677741
申请日:2015-04-02
申请人: Dadong ZHANG , Xu CAI , Chengyun YUE , Junfei LI , Yan HU , Peng HUANG , Zhirong TANG , Qiyi LUO
发明人: Dadong ZHANG , Xu CAI , Chengyun YUE , Junfei LI , Yan HU , Peng HUANG , Zhirong TANG , Qiyi LUO
CPC分类号: A61L31/10 , A61F2/82 , A61F2250/0067 , A61F2250/0068 , A61L31/146 , A61L31/16 , A61L2300/416 , A61L2420/02 , C08L75/04 , C08L67/04 , C08L89/00 , C08L33/10 , C08L5/08
摘要: An interventional medical device and manufacturing method thereof. The interventional medical device comprises: a stent body (1); a surface of the stent body (1) being provided with a drug releasing structure (3), and drug in the drug releasing structure (3) being drug for suppressing proliferation of adventitial fibroblasts and a drug for suppressing proliferation of intimal and/or smooth muscle cells. In use, after interventional medical device is implanted into a human body, the drug for suppressing proliferation of adventitial fibroblasts carried thereon can promote the compensatory expansion of the vessel, and the drug for suppressing proliferation of intimal cells and/or smooth muscle cells carried thereon can suppress intimal proliferation of the vessel. The combination of the two kinds of drugs greatly reduces the occurrence rate of in-stent restenosis.
摘要翻译: 介入医疗装置及其制造方法。 介入医疗装置包括:支架主体(1); 支架体(1)的表面设有药物释放结构(3),药物释放结构(3)中的药物是抑制外膜成纤维细胞增殖的药物和抑制内膜和/或平滑增生的药物 肌肉细胞。 在使用中,将介入医疗装置植入人体后,用于抑制携带的外膜成纤维细胞增殖的药物可以促进血管的代偿性扩张,并且抑制其上承载的内膜细胞和/或平滑肌细胞增殖的药物 可以抑制血管的内膜增殖。 两种药物的组合大大降低了支架内再狭窄的发生率。
-
公开(公告)号:US09433709B2
公开(公告)日:2016-09-06
申请号:US14677741
申请日:2015-04-02
申请人: Dadong Zhang , Xu Cai , Chengyun Yue , Junfei Li , Yan Hu , Peng Huang , Zhirong Tang , Qiyi Luo
发明人: Dadong Zhang , Xu Cai , Chengyun Yue , Junfei Li , Yan Hu , Peng Huang , Zhirong Tang , Qiyi Luo
CPC分类号: A61L31/10 , A61F2/82 , A61F2250/0067 , A61F2250/0068 , A61L31/146 , A61L31/16 , A61L2300/416 , A61L2420/02 , C08L75/04 , C08L67/04 , C08L89/00 , C08L33/10 , C08L5/08
摘要: An interventional medical device and manufacturing method thereof. The interventional medical device comprises: a stent body (1); a surface of the stent body (1) being provided with a drug releasing structure (3), and drug in the drug releasing structure (3) being drug for suppressing proliferation of adventitial fibroblasts and a drug for suppressing proliferation of intimal and/or smooth muscle cells. In use, after interventional medical device is implanted into a human body, the drug for suppressing proliferation of adventitial fibroblasts carried thereon can promote the compensatory expansion of the vessel, and the drug for suppressing proliferation of intimal cells and/or smooth muscle cells carried thereon can suppress intimal proliferation of the vessel. The combination of the two kinds of drugs greatly reduces the occurrence rate of in-stent restenosis.
摘要翻译: 介入医疗装置及其制造方法。 介入医疗装置包括:支架主体(1); 支架体(1)的表面设有药物释放结构(3),药物释放结构(3)中的药物是抑制外膜成纤维细胞增殖的药物和抑制内膜和/或平滑增生的药物 肌肉细胞。 在使用中,将介入医疗装置植入人体后,用于抑制携带的外膜成纤维细胞增殖的药物可以促进血管的代偿性扩张,并且抑制其上承载的内膜细胞和/或平滑肌细胞增殖的药物 可以抑制血管的内膜增殖。 两种药物的组合大大降低了支架内再狭窄的发生率。
-
公开(公告)号:US20050210598A1
公开(公告)日:2005-09-29
申请号:US11079895
申请日:2005-03-14
申请人: Duncan Whitehead , Justin Silvia , David Pettey , Xu Cai
发明人: Duncan Whitehead , Justin Silvia , David Pettey , Xu Cai
CPC分类号: D06B21/00
摘要: A method for producing an improved washed and plushed upholstery fabric in a continuous process includes the provision of a soft, dimensionally stable, nonwoven fabric backing. After the chemical application of an anti-migrant and softener, the fabric is washed in a rope form, opened and de-twisted. After the fabric is rewound and further coatings are applied, an adhesive is applied to hold a nonwoven web to the previously prepared fabric in a rewinding process. The fabric is then subjected to a steam flow process to enhance the fabric texture and reduce the width of the fabric.
摘要翻译: 在连续方法中制造改进的洗涤和加成的内饰织物的方法包括提供柔软的,尺寸稳定的非织造织物背衬。 化学应用反迁移剂和软化剂后,织物以绳索形式洗涤,打开和扭曲。 在织物重新卷绕并进一步涂布之后,施加粘合剂以在重绕过程中将非织造纤维网保持在预先制备的织物上。 然后对织物进行蒸汽流程以增强织物纹理并减小织物的宽度。
-
4.
公开(公告)号:US20220237681A1
公开(公告)日:2022-07-28
申请号:US17157649
申请日:2021-01-25
摘要: Artificial intelligence (AI) assisted technology for grocery recommendations and nutrient optimization includes an intuitive application (app) that can use AI to improve grocery recommendations during grocery shopping to optimize nutrition and encourage users to purchase foods that can help the user receive more complete nutrition. Automatically capturing nutritional information while grocery shopping can assist users seeking to improve their health because it operates while users are performing their grocery shopping, when users have the best opportunity to shape the foods that will be available to them to consume. Nutritional optimization while grocery shopping can improve the use of resources including time and money (due to the cost of food) because it can provide suggestions to address nutritional opportunities that represent nutritional surpluses and nutritional opportunities that represent nutritional deficits. Nutritional optimization while grocery shopping can recommend complementary food items to improve nutritional deficits while minimizing nutritional surplus.
-
公开(公告)号:US20140248327A1
公开(公告)日:2014-09-04
申请号:US14348857
申请日:2012-01-16
申请人: Dadong Zhang , Xu Cai , Chengyun Yue , Junfei Li , Yan Hu , Peng Huang , Zhirong Tang , Qiyi Luo
发明人: Dadong Zhang , Xu Cai , Chengyun Yue , Junfei Li , Yan Hu , Peng Huang , Zhirong Tang , Qiyi Luo
CPC分类号: A61L31/10 , A61F2/82 , A61F2250/0067 , A61F2250/0068 , A61L31/146 , A61L31/16 , A61L2300/416 , A61L2420/02 , C08L75/04 , C08L67/04 , C08L89/00 , C08L33/10 , C08L5/08
摘要: An interventional medical device and manufacturing method thereof. The interventional medical device comprises: a stent body (1); a surface of the stent body (1) being provided with a drug releasing structure (3), and drug in the drug releasing structure (3) being drug for suppressing proliferation of adventitial fibroblasts and a drug for suppressing proliferation of intimal and/or smooth muscle cells. In use, after interventional medical device is implanted into a human body, the drug for suppressing proliferation of adventitial fibroblasts carried thereon can promote the compensatory expansion of the vessel, and the drug for suppressing proliferation of intimal cells and/or smooth muscle cells carried thereon can suppress intimal proliferation of the vessel. The combination of the two kinds of drugs greatly reduces the occurrence rate of in-stent restenosis.
摘要翻译: 介入医疗装置及其制造方法。 介入医疗装置包括:支架主体(1); 支架体(1)的表面设有药物释放结构(3),药物释放结构(3)中的药物是抑制外膜成纤维细胞增殖的药物和抑制内膜和/或平滑增生的药物 肌肉细胞。 在使用中,将介入医疗装置植入人体后,用于抑制携带的外膜成纤维细胞增殖的药物可以促进血管的代偿性扩张,并且抑制其上承载的内膜细胞和/或平滑肌细胞增殖的药物 可以抑制血管的内膜增殖。 两种药物的组合大大降低了支架内再狭窄的发生率。
-
公开(公告)号:US20150004207A1
公开(公告)日:2015-01-01
申请号:US14348815
申请日:2012-01-17
申请人: Xu Cai , Dadong Zhang , Yan Hu , Peng Huang , Junfei Li , Chengyun Yue , Zhirong Tang , Qiyi Luo
发明人: Xu Cai , Dadong Zhang , Yan Hu , Peng Huang , Junfei Li , Chengyun Yue , Zhirong Tang , Qiyi Luo
CPC分类号: A61L31/10 , A61F2/82 , A61F2002/0086 , A61F2240/00 , A61L31/146 , A61L31/16 , A61L2300/416 , A61L2400/00 , A61L2420/02 , A61L2420/06 , B05B17/06 , B05D1/02 , B05D1/18
摘要: An interventional medical device and manufacturing method thereof, the interventional medical device comprising a stent body (1); the stent body (1) is provided with a drug releasing structure on the surface, the drug in the drug releasing structure being a drug for inhibiting adventitial fibroblast proliferation. When the interventional medical device is implanted into a human body, the drug for inhibiting the adventitial fibroblast proliferation can be slowly released into vessel wall cells in contact with the stent body (1), thus inhibiting the proliferation of the adventitial fibroblasts, promoting vascular compensatory expansion, and reducing the incidence rate of instent restenosis.
摘要翻译: 一种介入医疗装置及其制造方法,所述介入医疗装置包括支架主体(1); 支架体(1)在表面设置有药物释放结构,药物释放结构中的药物是用于抑制外膜成纤维细胞增殖的药物。 当将介入医疗器械植入人体内时,用于抑制外膜成纤维细胞增殖的药物可以缓慢释放到与支架体(1)接触的血管壁细胞中,从而抑制外膜成纤维细胞的增殖,促进血管补偿 扩张,并减少局限性再狭窄的发生率。
-
公开(公告)号:US20130304191A1
公开(公告)日:2013-11-14
申请号:US13884642
申请日:2011-08-16
申请人: Xu Cai , Dadong Zhang , Changchun Wang , Zhirong Tang , Qiyi Luo , Zhaohua Chang
发明人: Xu Cai , Dadong Zhang , Changchun Wang , Zhirong Tang , Qiyi Luo , Zhaohua Chang
IPC分类号: A61F2/82
CPC分类号: A61F2/82 , A61F2/856 , A61F2/915 , A61F2002/067 , A61F2002/91575 , A61F2250/0096 , A61F2250/0098
摘要: A stent for a bifurcated vessel comprises a stent body having two open ends, wherein at least one of the open ends of the stent body is a wedge structure, a second opaque marker is provided on the two ends of the slant long axis of the wedge structure, the stent body is provided with two first opaque markers, and the connecting line between the two first opaque markers is parallel to the slant of the wedge structure. When the two first opaque markers overlap with each other, the slant of the wedge structure of the stent for a bifurcated vessel is precisely positioned during implantation so that the slant of the wedge structure of the stent for a bifurcated vessel fits the slant at the blood vessel bifurcation site.
摘要翻译: 用于分叉血管的支架包括具有两个开口端的支架主体,其中支架主体的开口端中的至少一个是楔形结构,在楔形物的倾斜长轴的两端设置第二不透明标记 结构中,支架主体设置有两个第一不透明标记,两个第一不透明标记之间的连接线平行于楔形结构的倾斜。 当两个第一不透明标记彼此重叠时,用于分叉血管的支架的楔形结构的倾斜在植入期间被精确地定位,使得用于分叉血管的支架的楔形结构的斜面适合于在血液处的倾斜 血管分叉位置。
-
-
-
-
-
-